Deeba Husain is an Ophthalmology physician affiliated with Massachusetts Eye and Ear Infirmary. OpenAlex indexes 401 publications with 6,761 citations (h-index 44). By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
243 Charles St
12th Floor
Boston, MA 021143002
Telephone
671-573-4074Registry record last updated 10 May 2013.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Inspire Medical Systems, Inc.Program year20251 payment
- Genentech USA, Inc.Program year20241 payment
- Genentech USA, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
80.6%Corticosteroid67.7%Prednisolone Acetate79%Dexamethasone Sodium Phosphate21%Part D<11 patientsNonsteroidal Anti-inflammatory Drug12.9%Bromfenac Sodium100%Part D<11 patientsMusculoskeletal
19.4%Cyclooxygenase Inhibitor19.4%Ketorolac Tromethamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2025 per NIH RePORTER. The latest:
- Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration
Massachusetts Eye and Ear Infirmary
FY2025$706,337R01EY030088 - Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration
Massachusetts Eye and Ear Infirmary
FY2024$419,891R01EY030088 - Metabolomics a Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration
Massachusetts Eye and Ear Infirmary
FY2023$420,031R01EY030088
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Contrast sensitivity function in patients with macular disease and good visual acuity
British Journal of Ophthalmology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
John Kempen, MD
Massachusetts Eye and Ear Infirmary
Neil Bhattacharyya, MD, FACS
Massachusetts Eye and Ear Infirmary
Demetrios Vavvas, MD, PhD
Massachusetts Eye and Ear Infirmary
Evangelos Gragoudas, MD
Massachusetts Eye and Ear Infirmary
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”